Aleo BME has developed a pipeline of 510K and premarket approval programs that are at various stages of development. The pipeline represents the lead candidates from Aleo's library of polymeric compounds that have been qualified using rigorous, iterative assays deemed critical to medical device and cosmetic applications. The most advanced programs are currently targeting commercially attractive opportunities in the areas of tissue repair and regeneration and cancer surgical removal. Programs for medical device coatings and agricultural fertilizer enhancers are kicking off. Aleo BME is open to visionary industrial leaders and investors for potential partnership and investment opportunities.